EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA

Clinical trials for EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to outsmart tough lung cancer

Disease control Ongoing

This study is testing if adding an experimental drug called berzosertib (M6620) to standard chemotherapy (topotecan) works better than chemotherapy alone for adults whose small cell lung cancer has come back. The goal is to see if the combination can help control the cancer for l…

Matched conditions: EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA

Get alerted when new EXTRAPULMONARY SMALL CELL NEUROENDOCRINE CARCINOMA trials appear

New drug combo aims to outsmart tough lung cancer